133 related articles for article (PubMed ID: 34340930)
21. Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019.
Fukuda Y; Tsugawa T; Nagaoka Y; Ishii A; Nawa T; Togashi A; Kunizaki J; Hirakawa S; Iida J; Tanaka T; Kizawa T; Yamamoto D; Takeuchi R; Sakai Y; Kikuchi M; Nagai K; Asakura H; Tanaka R; Yoshida M; Hamada R; Kawasaki Y
J Infect Chemother; 2021 Nov; 27(11):1639-1647. PubMed ID: 34389224
[TBL] [Abstract][Full Text] [Related]
22. Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.
Tokuda Y; Barnett PB; Sanji S; Takaizumi Y; Tomono M; Tokuda H; Taniguchi K; Shibuya K
Gen Hosp Psychiatry; 2023; 82():1-6. PubMed ID: 36868102
[TBL] [Abstract][Full Text] [Related]
23. Early experience with arterial thromboembolic complications in patients with COVID-19.
Indes JE; Koleilat I; Hatch AN; Choinski K; Jones DB; Aldailami H; Billett H; Denesopolis JM; Lipsitz E
J Vasc Surg; 2021 Feb; 73(2):381-389.e1. PubMed ID: 32861865
[TBL] [Abstract][Full Text] [Related]
24. Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study.
Takeyama M; Yachi S; Nishimoto Y; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M; Yamashita Y
J Epidemiol; 2023 Mar; 33(3):150-157. PubMed ID: 36372435
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
26. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?
El Hasbani G; Taher AT
Med Hypotheses; 2021 Jul; 152():110621. PubMed ID: 34116360
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
Billett HH; Reyes-Gil M; Szymanski J; Ikemura K; Stahl LR; Lo Y; Rahman S; Gonzalez-Lugo JD; Kushnir M; Barouqa M; Golestaneh L; Bellin E
Thromb Haemost; 2020 Dec; 120(12):1691-1699. PubMed ID: 33186991
[TBL] [Abstract][Full Text] [Related]
28. Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study).
Singh A; Dhir A; Kajal K; Naik NB; Lazar MS; Puri GD; Soni SL; Neupane A; Ganesh V; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhalla A
Indian J Med Res; 2022; 155(5&6):526-537. PubMed ID: 36124497
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.
Lazaridis D; Leung S; Kohler L; Smith CH; Kearson ML; Eraikhuemen N
J Pharm Pract; 2022 Dec; 35(6):1000-1006. PubMed ID: 33960219
[TBL] [Abstract][Full Text] [Related]
30. Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.
Hsu A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
Thromb Res; 2020 Dec; 196():375-378. PubMed ID: 32980620
[TBL] [Abstract][Full Text] [Related]
31. [Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
Ruzhentsova TA; Khavkina DA; Chukhliaev PV; Garbuzov AA; Ploskireva AA
Vopr Virusol; 2021 Mar; 66(1):40-46. PubMed ID: 33683064
[TBL] [Abstract][Full Text] [Related]
32. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
33. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
[TBL] [Abstract][Full Text] [Related]
34. Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States.
Rentsch CT; Beckman JA; Tomlinson L; Gellad WF; Alcorn C; Kidwai-Khan F; Skanderson M; Brittain E; King JT; Ho YL; Eden S; Kundu S; Lann MF; Greevy RA; Ho PM; Heidenreich PA; Jacobson DA; Douglas IJ; Tate JP; Evans SJ; Atkins D; Justice AC; Freiberg MS
medRxiv; 2020 Dec; ():. PubMed ID: 33330896
[TBL] [Abstract][Full Text] [Related]
35. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
[TBL] [Abstract][Full Text] [Related]
36. The intensity of anticoagulant dosing in hospitalized patients with COVID-19: An observational, comparative effectiveness study.
Myers LC; Xu S; Chen A; Greene JD; Creekmur B; Bruxvoort K; Escobar GJ; Adams JL; Langer-Gould A; Liu VX; Gould MK
J Hosp Med; 2023 Jan; 18(1):43-54. PubMed ID: 36345824
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study.
Yamashita Y; Yachi S; Takeyama M; Nishimoto Y; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M
Circ J; 2022 Jun; 86(7):1137-1142. PubMed ID: 35662177
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.
Ito Y; Awano N; Uchiyama F; Inomata M; Kuse N; Tone M; Takada K; Fujimoto K; Muto Y; Sagisaka S; Maki K; Yamashita R; Harada A; Nishimura JI; Hayashi M; Izumo T
Intern Med; 2021 Nov; 60(21):3503-3506. PubMed ID: 34433713
[TBL] [Abstract][Full Text] [Related]
39. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.
Santoro F; Núñez-Gil IJ; Vitale E; Viana-Llamas MC; Romero R; Maroun Eid C; Feltes Guzman G; Becerra-Muñoz VM; Fernández Rozas I; Uribarri A; Alfonso-Rodriguez E; García Aguado M; Huang J; Castro Mejía AF; Garcia Prieto JF; Elola J; Ugo F; Cerrato E; Signes-Costa J; Raposeiras Roubin S; Jativa Mendez JL; Espejo Paeres C; López Masjuan A; Marin F; Guerra F; El-Battrawy I; Cortese B; Ramakrishna H; Perez-Villacastín J; Fernandez-Ortiz A; Brunetti ND
J Am Heart Assoc; 2022 Jul; 11(13):e024530. PubMed ID: 35730631
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
